Literature DB >> 17656638

The role of the donor in the repair of the marrow vascular niche following hematopoietic stem cell transplant.

William B Slayton1, Xiao-Miao Li, Jason Butler, Steven M Guthrie, Marda L Jorgensen, John R Wingard, Edward W Scott.   

Abstract

Bone marrow sinusoids maintain homeostasis between developing hematopoietic cells and the circulation, and they provide niches for hematopoietic progenitors. Sinusoids are damaged by chemotherapy and radiation. Hematopoietic stem cells (HSCs) have been shown to produce endothelial progenitor cells that contribute to the repair of damaged blood vessels. Because HSCs home to the marrow during bone marrow transplant, these cells may play a role in repair of marrow sinusoids. Here, we explore the role of donor HSCs in the repair of damaged sinusoids following hematopoietic stem cell transplant. We used three methods to test this role: (a) expression of platelet endothelial cell adhesion molecule to identify endothelial progenitors and the presence of the Y chromosome to identify male donor cells in female recipients; (b) presence of the Y chromosome to identify male donor cells in female recipients, and expression of the panendothelial marker mouse endothelial cell antigen-32 to identify sinusoidal endothelium; and (c) use of Tie-2/green fluorescent protein mice as donors or recipients and presence of Dil-Ac-LDL to identify sinusoids. We found that sinusoids were predominantly host-derived posttransplant. Donor cells spread along the marrow vasculature early post-transplant in a pattern that matched stromal-derived factor-1 expression. Furthermore, these engrafting progenitors were positioned to provide physical support, as well as growth and survival signals in the form of vascular-endothelial growth factor-A. Occasionally, donor cells provide cellular "patches" in the damaged sinusoids, although this occurred at a low level compared with hematopoietic engraftment. Donor support for the repair of the marrow vascular niche may be a critical first step of hematopoietic engraftment.

Entities:  

Mesh:

Year:  2007        PMID: 17656638     DOI: 10.1634/stemcells.2007-0158

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  25 in total

1.  Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation.

Authors:  Massimo Dominici; Valeria Rasini; Rita Bussolari; Xiaohua Chen; Ted J Hofmann; Carlotta Spano; Daniela Bernabei; Elena Veronesi; Filippo Bertoni; Paolo Paolucci; PierFranco Conte; Edwin M Horwitz
Journal:  Blood       Date:  2009-05-11       Impact factor: 22.113

2.  Intrabone transplantation of CD34+ cells with optimized delivery does not enhance engraftment in a rhesus macaque model.

Authors:  Kate Stringaris; Robert F Hoyt; Jan K Davidson-Moncada; Jeremy M Pantin; John F Tisdale; Naoya Uchida; Lydia N Raines; Robert Reger; Noriko Sato; Cynthia E Dunbar; Timothy J Hunt; Randall R Clevenger; Allen Krouse; Mark E Metzger; Aylin C Bonifacino; William Telford; Peter L Choyke; Theresa Engels; Robert E Donahue; Richard W Childs
Journal:  Blood Adv       Date:  2020-12-22

3.  Involvement of bone marrow cells and neuroinflammation in hypertension.

Authors:  Monica M Santisteban; Niousha Ahmari; Jessica Marulanda Carvajal; Michael B Zingler; Yanfei Qi; Seungbum Kim; Jessica Joseph; Fernando Garcia-Pereira; Richard D Johnson; Vinayak Shenoy; Mohan K Raizada; Jasenka Zubcevic
Journal:  Circ Res       Date:  2015-05-11       Impact factor: 17.367

Review 4.  Targeting stem cell niches and trafficking for cardiovascular therapy.

Authors:  Nicolle Kränkel; Gaia Spinetti; Silvia Amadesi; Paolo Madeddu
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

5.  Human CD133-derived bone marrow stromal cells establish ectopic hematopoietic microenvironments in immunodeficient mice.

Authors:  Benjamin Bakondi; Jeffrey L Spees
Journal:  Biochem Biophys Res Commun       Date:  2010-08-16       Impact factor: 3.575

6.  Selective enhancement of donor hematopoietic cell engraftment by the CXCR4 antagonist AMD3100 in a mouse transplantation model.

Authors:  Yubin Kang; Benny J Chen; Divino Deoliveira; Jeffrey Mito; Nelson J Chao
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

7.  Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units.

Authors:  C G Brunstein; J N Barker; D J Weisdorf; T E Defor; D McKenna; S Y Chong; J S Miller; P B McGlave; J E Wagner
Journal:  Bone Marrow Transplant       Date:  2009-01-12       Impact factor: 5.483

8.  High levels of acetylated low-density lipoprotein uptake and low tyrosine kinase with immunoglobulin and epidermal growth factor homology domains-2 (Tie2) promoter activity distinguish sinusoids from other vessel types in murine bone marrow.

Authors:  Xiao-Miao Li; Zhongbo Hu; Marda L Jorgenson; William B Slayton
Journal:  Circulation       Date:  2009-10-26       Impact factor: 29.690

9.  On the adaptation of endosteal stem cell niche function in response to stress.

Authors:  Yi Jiang; Halvard Bonig; Tatiana Ulyanova; KaiHsin Chang; Thalia Papayannopoulou
Journal:  Blood       Date:  2009-09-01       Impact factor: 22.113

10.  Endothelial cells mediate the regeneration of hematopoietic stem cells.

Authors:  Bei Li; Alexis S Bailey; Shuguang Jiang; Bin Liu; Devorah C Goldman; William H Fleming
Journal:  Stem Cell Res       Date:  2009-08-13       Impact factor: 2.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.